|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/768 | (2015.01) |
| A61K 39/39541 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 35/768 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 16/2818 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K2039/507 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3612201 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18723290.5 |
| Date of filing the European patent application | 2018-04-23 | |
| (97) | Date of publication of the European application | 2020-02-26 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/028952 |
| Date | 2018-04-23 |
| (87) | Number | WO 2018/195552 |
| Date | 2018-10-25 |
| (30) | Number | Date | Country code |
| 201762488623 P | 2017-04-21 | US | |
| 201762550486 P | 2017-08-25 | US |
| (72) |
KIM, Chan , KR
JEON, Hongjae , KR
MOON, Eun, Sang , KR
CHI, Sungkuon , KR
CHOI, Jiwon, Sarah , KR
JUNG, Joon-goo , KR
BAE, Jungu , KR
|
| (73) |
Sillajen, Inc. ,
607-ho 6F 111 Hyoyeol-ro
Buk-gu, Busan 46508,
KR
|
| (54) | ONCOLYTIC VACCINIA VIRUS AND CHECKPOINT INHIBITOR COMBINATION THERAPY |
| ONCOLYTIC VACCINIA VIRUS AND CHECKPOINT INHIBITOR COMBINATION THERAPY |